Screening of differentially expressed genes and identification of AMACR as a prognostic marker in prostate cancer
Authors:
- 16 April 2021
- journal article
- research article
- Published by Wiley in Andrologia
- Vol. 53 (6) , e14067
Abstract
Prostate cancer, the second most common cancer found in male over the world, was estimated to have 191,930 new cases and 33,330 deaths in 2020 in the United States. Prostate cancer is very common in male, about 12.1% of men will acquire this cancer in their lifetime, and a higher risk was reported in older men and African American men. Gene deregulations have been found to be extensively associated with cancer development. To gain further insight into how gene deregulation affects prostate cancer, we analysed three gene profiling datasets of prostate cancer from Gene Expression Omnibus (GEO) applying bioinformatic tools in our study. Firstly, we identified common differently expressed genes (DEGs) shared by the three gene profiling datasets, constructed protein–protein interaction network and determined top 10 hub genes. Further DEGs validation in TCGA and Human Protein Atlas Database identified AMACR as the core gene. We then analysed the role of AMACR in prostate cancer cell lines and found that AMACR‐knockdown resulted in the decreased cell proliferation and increased apoptosis. These results suggest an oncogenic role of AMACR in prostate cancer, and it could be a potential biomarker for the diagnosis of prostate cancer.Keywords
This publication has 37 references indexed in Scilit:
- Identification of genomic functional hotspots with copy number alteration in liver cancerEURASIP Journal on Bioinformatics and Systems Biology, 2013
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stressNature, 2012
- Turnover of Focal Adhesions and Cancer Cell MigrationInternational Journal of Cell Biology, 2012
- Deep sequencing reveals distinct patterns of DNA methylation in prostate cancerGenome Research, 2011
- Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressGenes & Development, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachmentNature, 2009
- Deletion Hotspots in AMACR Promoter CpG Island Are cis-Regulatory Elements Controlling the Gene Expression in the ColonPLOS Genetics, 2009
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002